The Abelson and Moloney murine leukemia virus complex (A-MuLV/M-MuLV) induces rapidly growing thymic lymphomas following direct injection into the thymus of newborn BALB/c and C57BL/6 mice. Southern blot analysis with a v-abl specific probe not only demonstrated that primary tumors are clonal, but also that the pattern of A-MuLV provirus integration is quite stable in primary tumor cells, as well as in their derived cell lines and clones. Most of the cell samples were able to rearrange the immunoglobulin heavy chain genes in culture, whereas in two cases the T cell receptor gamma chain genes also underwent rearrangement. Since the recombination mechanism is operative only in very immature lymphoid cells, these data provide indirect evidence for the lack of differentiation of A-MuLV cell targets in the thymus.
Get full access to this article
View all access options for this article.
References
1.
CookW.D.: Rapid thymomas induced by Abelson murine leukemia virus. Proc. Natl. Acad. Sci. U.S.A., 79: 2917–2921, 1982.
2.
CookW.D., BalatonA.M.: T-cell receptor and immunoglobulin genes are rearranged together in Abelson virus-transformed pre-B and pre-T cells. Mol. Cell. Biol., 7: 266–272, 1985.
3.
CookW.D., MetcalfD., NicolaN.A., BurgessA.W., WalkerF.: Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism. Cell, 41: 677–683, 1985.
4.
D'AndreaE., SaggioroD., FleissnerE., Chieco-BianchiL.: Abelson murine leukemia virus-induced thymic lymphomas: transformation of a primitive lymphoid precursor. JNCI, 79: 189–195, 1986.
5.
FeinbergA.P., VogelsteinB.: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132: 6–13, 1983.
6.
GoffS., GilboaE., WitteO.N., BaltimoreD.: Structure of the Abelson murine leukemia virus genome and the homologous cellular gene. Studies with cloned viral DNA. Cell, 22: 777–785, 1980.
7.
GreavesM.F., ChanL.C., FurleyA.J.W., WattS.M., MolgaardH.V.: Lineage promiscuity in hemopoietic differentiation and leukemia. Blood, 67: 1–11, 1986.
8.
GreenP.L., KaehlerD.H., RisserR.: Clonal dominance and progression in Abelson murine leukemia virus lymphomagenesis. J. Virol., 61: 2192–2197, 1987.
9.
HaydayA.C., SaitoH., GilliesS.D., KranzD.M., TanigawaG., EisenH.N., TonegawaS.: Structure organization and somatic rearrangement of T cell gamma genes. Cell, 40: 259–269, 1985.
10.
ManiatisT., FritschE., SambrookJ.: Molecular cloning. A laboratory manual.Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., 1982.
11.
MarcuK.B., BannerjiJ., PenncavageN.A., LangR., ArnheimN.: 5′ flanking region of immunoglobulin heavy chain constant region genes displays length heterogeneity in germlines of inbred mouse strains. Cell, 22: 187–196, 1980.
12.
PierceJ.H., Di FioreP.P., AaronsonS.A., PotterM., PumphreyJ., ScottA., IhleJ.N.: Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism. Cell, 41: 685–693, 1985.
13.
PoirierY., KozakC., JolicoeurP.: Identification of a common helper provirus integration site in Abelson murine leukemia virus-induced lymphoma DNA. J. Virol., 62: 3985–3992, 1988.
14.
RaschkeW.C., BairdS., RalphP., NakoinzI.: Functional macrophage cell line transformed by Abelson leukemia virus. Cell, 15: 261–267, 1978.
15.
RethM.G., AmmiratiP., JacksonS., AltF.W.: Regulated progression of a cultured pre-B-cell line to the B-cell stage. Nature, 317: 353–355, 1985.
16.
RisserR.: The pathogenesis of Abelson virus lymphomas of the mouse. Biochim. Biophys. Acta, 651: 213–244, 1982.
17.
RisserR., KoehlerD., LamphW.W.: Different genes control the susceptibility of mice to Moloney or Abelson leukemia viruses. J. Virol., 55: 547–553, 1985.
18.
RosenbergN., BaltimoreD., ScherC.D.: In vitro transformation of lymphoid cells by Abelson murine leukemia virus. Proc. Natl. Acad. Sci., U.S.A., 72: 1930–1932, 1975.
19.
RosenbergN., BaltimoreD.: A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus. J. Exp. Med., 143: 1453–1463, 1976.
20.
SaggioroD., Di RenzoM.F., ComoglioP.M., Chieco-BianchiL.: Different cellular substrates of Abelson leukemia virus transforming protein kinase in murine fibroblasts and lymphocytes. In: Modern Trends in Human Leukemia VI, NethGallo, GreavesJanka (Eds.), pp. 298–301, Springer-Verlag, Berlin - Heidelberg, 1985.
21.
SaggioroD., FerraciniR., Di RenzoM.F., NaldiniL., Chieco-BianchiL., ComoglioP.M.: Protein phosphorylation at tyrosine residues in v-abl transformed mouse lymphocytes and fibroblasts. Int. J. Cancer, 37: 623–628, 1986.
22.
SaggioroD., ZamarchiR., D'AndreaE., Chieco-BianchiL.: In vitro malignant progression of cells derived from Abelson murine leukaemia virus-induced thymic lymphomas. Br. J. Cancer, 58: 152–157, 1988.
23.
ScherC.D., SieglerR.: Direct transformation of 3T3 cells by Abelson murine leukemia virus. Nature, 253: 729–731, 1975.
24.
ScottM.L., DavisM.M., FeinbergM.B.: Transformation of T-lymphoid cells by Abelson murine leukemia virus. J. Virol., 59: 434–443, 1986.
25.
SeftonB.M., HunterT., RaschkeW.C.: Evidence that the Abelson virus protein functions in vivo as a protein kinase that phosphorylates tyrosine. Proc. Natl. Acad. Sci., U.S.A., 78: 1552–1556, 1981.
26.
SouthernE.M.: Detection of specific sequences among fragments separated by gel electrophoresis. J. Mol. Biol., 98: 503–517, 1975.
27.
WhitlockC.A., ZieglerS.F., WitteO.N.: Progression of the transformed phenotype in clonal lines of Abelson virus-infected lymphocytes. Mol. Cell. Biol., 3: 596–604, 1983.
28.
WhitlockC.A., WitteO.N.: The complexity of virus-cell interactions in Abelson virus infection of lymphoid and other hematopoietic cells. Adv. Immunol., 37: 73–98, 1985.
